Trans-4-(4-Chlorophenyl)pyrrolidine-3-carboxylic acid hydrochloride is a chiral pyrrolidine derivative characterized by a trans-configured 3-carboxylic acid and a 4-(4-chlorophenyl) substituent. It is typically supplied as a hydrochloride salt to enhance stability and solubility. This compound serves as a crucial synthetic intermediate in pharmaceutical research and development. Its primary and most significant application is in the synthesis of novel, potent, and selective dopamine D4 receptor antagonists. Research publications and patent literature specifically highlight its use in constructing advanced molecular scaffolds aimed at treating central nervous system disorders. These potential therapeutic agents target conditions such as schizophrenia, cognitive deficits, and other neuropsychiatric illnesses where dopamine D4 receptor modulation is implicated. As a building block containing both a privileged pyrrolidine heterocycle and a chlorophenyl group, it provides a versatile chiral template for medicinal chemistry. Handling requires standard laboratory precautions for organic compounds, including the use of personal protective equipment due to its potential irritant properties.